Results
|
1.
|
|
|
2.
|
Early prediction of a long-term outcome by neutrophil-FISH in patients with CML receiving imatinib mesylate. [electronic resource] by
- Takahashi, Naoto
- Kameoka, Yoshihiro
- Tagawa, Hiroyuki
- Saitoh, Hirobumi
- Yoshioka, Tomoko
- Fujishima, Naohito
- Kitabayashi, Atsushi
- Takahashi, Kaoru
- Hirokawa, Makoto
- Sawada, Kenichi
Producer: 20110128
In:
International journal of hematology vol. 92
Availability: No items available.
|
|
3.
|
Hypoxia-inducible microRNA-210 regulates the DIMT1-IRF4 oncogenic axis in multiple myeloma. [electronic resource] by
- Ikeda, Sho
- Kitadate, Akihiro
- Abe, Fumito
- Saitoh, Hirobumi
- Michishita, Yoshihiro
- Hatano, Yoshiaki
- Kawabata, Yoshinari
- Kitabayashi, Atsushi
- Teshima, Kazuaki
- Kume, Masaaki
- Takahashi, Naoto
- Tagawa, Hiroyuki
Producer: 20170926
In:
Cancer science vol. 108
Availability: No items available.
|
|
4.
|
Bortezomib reduces the tumorigenicity of multiple myeloma via downregulation of upregulated targets in clonogenic side population cells. [electronic resource] by
- Nara, Miho
- Teshima, Kazuaki
- Watanabe, Atsushi
- Ito, Mitsugu
- Iwamoto, Keiko
- Kitabayashi, Atsushi
- Kume, Masaaki
- Hatano, Yoshiaki
- Takahashi, Naoto
- Iida, Shinsuke
- Sawada, Kenichi
- Tagawa, Hiroyuki
Producer: 20130827
In:
PloS one vol. 8
Availability: No items available.
|
|
5.
|
Fluorescence in situ hybridization monitoring of BCR-ABL-positive neutrophils in chronic-phase chronic myeloid leukemia patients during the primary stage of imatinib mesylate therapy. [electronic resource] by
- Takahashi, Naoto
- Miura, Ikuo
- Kobayashi, Yoshimi
- Kume, Masaaki
- Yoshioka, Tomoko
- Otane, Wataru
- Ohtsubo, Kaori
- Takahashi, Kaoru
- Kitabayashi, Atsushi
- Kawabata, Yoshinari
- Hirokawa, Makoto
- Nishijima, Hirokazu
- Ichinohasama, Ryo
- Decoteau, John
- Miura, Akira B
- Sawada, Ken-Ichi
Producer: 20050616
In:
International journal of hematology vol. 81
Availability: No items available.
|
|
6.
|
Treatment of multiple myeloma in Akita: features and outcomes in the era of novel agents. [electronic resource] by
- Shida, Seiji
- Takahashi, Naoto
- Niioka, Takenori
- Kitabayashi, Atsushi
- Kawabata, Yoshinari
- Kume, Masaaki
- Saitoh, Hirobumi
- Hatano, Yoshiaki
- Ichikawa, Yoshikazu
- Kuroki, Jun
- Motegi, Mutsuhito
- Kobayashi, Takahiro
- Kameoka, Yoshihiro
- Tagawa, Hiroyuki
- Fujishima, Naohito
- Yoshioka, Tomoko
- Hirokawa, Makoto
- Miura, Masatomo
- Sawada, Kenichi
Producer: 20150129
In:
Journal of clinical and experimental hematopathology : JCEH vol. 54
Availability: No items available.
|
|
7.
|
Multicenter phase II clinical trial of nilotinib for patients with imatinib-resistant or -intolerant chronic myeloid leukemia from the East Japan CML study group evaluation of molecular response and the efficacy and safety of nilotinib. [electronic resource] by
- Takahashi, Naoto
- Miura, Masatomo
- Kuroki, Jun
- Mitani, Kinuko
- Kitabayashi, Atsushi
- Sasaki, Osamu
- Kimura, Hideo
- Imai, Kiyotoshi
- Tsukamoto, Norifumi
- Noji, Hideyoshi
- Kondo, Takeshi
- Motegi, Mutsuhito
- Kato, Yuichi
- Mita, Masayuki
- Saito, Hajime
- Yoshida, Chikashi
- Torimoto, Yoshihiro
- Kimura, Tomofumi
- Wano, Yuji
- Nomura, Jun
- Yamamoto, Satoshi
- Mayama, Ko
- Honma, Riko
- Sugawara, Tomohiro
- Sato, Shinji
- Shinagawa, Atsushi
- Abumiya, Maiko
- Niioka, Takenori
- Harigae, Hideo
- Sawada, Kenichi
Producer: 20140325
In:
Biomarker research vol. 2
Availability: No items available.
|